Heterotopic caval valve implantation in severe tricuspid regurgitation

Sharma, Neeraj Kumar; Chouhan, Nagendra; Bansal, Manish; Chandra, Praveen; Singh, Ajmer; Juneja, Rajiv; Mehta, Yatin; Trehan, Naresh

doi:10.4103/aca.aca_72_20

Cited by 3 publications

(1 citation statement)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…#Adopted from Straubinger HJ (2021) [ 20 ]. ǂAdopted from Sharma NK et al ., (2021) [ 25 ]. §Adopted from Riede FT, & Dähnert I (2012) [ 22 ].…”

Section: Evolution Of Transcatheter Tricuspid Prosthesismentioning

confidence: 99%

A Systematic Review of the Design, Method of Implantation and Early Clinical Outcomes of Transcatheter Tricuspid Prostheses

Sazzad¹,

Zhu²,

Leo³

et al. 2023

Rev. Cardiovasc. Med.

View full text Add to dashboard Cite

Background: Intervention for tricuspid regurgitation (TR) tends to happen concurrently with and is addressed during mitral valve surgery. Isolated TR interventions, however, are not unusual and are becoming more common. The purpose of this study was to provide a general overview of the transcatheter tricuspid valve implantation (TTVI) devices, taking into account the several design variations, and to unify the implantation technique, existing clinical results, and potential future directions for TR replacement therapy. Methods: The major databases, namely Pubmed via Medline, Embase, and Cochrane library, were systematically searched from the date of conception until 10 February 2023, in accordance with the preferred reporting items for systematic reviews and meta-analyses (PRISMA) standards. Results: Eleven studies were isolated from a total cohort of 5842 publications. All the transcatheter tricuspid prostheses were circular in design yet categorized into annular tricuspid valve implantation (ATVI) and caval valve implantation (CAVI) groups. Bleeding (25.2%), severe access site and vascular issues requiring intervention (5.8%), device migration or embolization (3.6%), and paravalvular leak (38%) are among the early TTVI-related complications that have been observed. The CAVI group experienced 3 of 28 bleeding cases and 2 of 4 device migration cases. Conclusions: Following the intervention with a transcatheter tricuspid prosthesis, this review discovered an early favorable outcome and a general improvement in heart failure symptoms. However, there was a lot of variation in their design, implantation technique, and early clinical outcomes. Understanding the design variations, difficulty of implantation and learning from this review’s key findings could help with the future development of catheter-based tricuspid valves. Systematic Review Registration: .

show abstract

“…#Adopted from Straubinger HJ (2021) [ 20 ]. ǂAdopted from Sharma NK et al ., (2021) [ 25 ]. §Adopted from Riede FT, & Dähnert I (2012) [ 22 ].…”

Section: Evolution Of Transcatheter Tricuspid Prosthesismentioning

confidence: 99%